# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-014439
Filing Date
2023-04-25
Accepted
2023-04-25 16:14:08
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | rkda-fy22-defa14a.htm | DEFA14A | 19774
2 | GRAPHIC | img178355871_0.jpg | GRAPHIC | 442063
3 | GRAPHIC | img178355871_1.jpg | GRAPHIC | 401373
| Complete submission text file | 0000950170-23-014439.txt |  | 1084754

Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37383 | Film No.: 23845048
SIC: 0100 Agricultural Production-Crops